Axoltis Pharma Overview
Founded
2003
Status
Private
Employees
2
Latest Deal Type
Series A
Latest Deal Amount
$1.24M
Investors
7
Axoltis Pharma General Information
Description
Developer of first-in-class innovative drugs designed to treat patients suffering from traumatic or severe neurological disorders. The company's drugs support neural repair in order to treat traumatic or severe degenerative disorders of the central nervous system faced with high unmet medical needs, enabling patients with the extension of its potential to the treatment of neurodegenerative diseases and o improve the patients' functional recovery and quality of life.
Contact Information
Website
Formerly Known As
Neuronax
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 15 - 17, Rue du Pré de la Reine
- 63100 Clermont-Ferrand
- France
+33 04 00 00 00 00
Axoltis Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 19-Dec-2014 | $1.24M | 00.000 | Completed | Profitable | |
| 1. Grant | 01-Oct-2012 | 00000 | Completed | Generating Revenue |
Axoltis Pharma Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yann Godfrin Ph.D | Chief Executive Officer & Chairman | ||
| Manuel Blanc Ph.D | Chief Scientific Officer | ||
| Pierre-Yves Simonin | Co-Founder |
3 Former Executives
Axoltis Pharma Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| François Miceli | Sofimac Investment Managers | Supervisory Board Member | 000 0000 |
| Philippe du Mesnil | Self | Supervisory Board Member | 000 0000 |
| Yann Godfrin Ph.D | Axoltis Pharma | Chief Executive Officer & Chairman | 000 0000 |
Axoltis Pharma Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Angelor Capitale | Angel Group | Minority | 000 0000 | 000000 0 | |
| Auvergne Business Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| FaDiese | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Individual Investor | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| JEREMIE Auvergne | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial